Our Bureau, Mumbai Saturday, June 14, 2025, 13:30 Hrs [IST] ...

Chiesi Group signs global licensing pact with Key2Brain to advance BBB-crossing therapies for lysosomal storage disorders: Parma, Italy Saturday, June 14, 2025, 16:00 Hrs [IST] Ch ...

Merck Animal Health receives EU CVMP positive opinion for Numelvi tablets for dogs: Rahway, New Jersey Saturday, June 14, 2025, 13:00 Hrs [IST] Merck Animal Health, known as MSD A ...

Neurent Medical receives US FDA’s 510(k) clearance for its next generation Neuromark system: Galway, Ireland Saturday, June 14, 2025, 17:00 Hrs [IST] Galway-headquartered Neuren ...

AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research: Cambridge, UK Saturday, June 14, 2025, 09:00 Hrs [IST] AstraZeneca has entered a ...

Our Bureau, Mumbai Friday, June 13, 2025, 16:50 Hrs [IST] ...

Bristol Myers Squibb presents data across targeted protein degradation research including CELMoD agents and BCL6 ligand-directed degrader at EHA 2025: Princeton, New Jersey Friday ...

Shilpa Medicare inks commercial supply deal with Orion for innovative recombinant human albumin: Our Bureau, Bengaluru Friday, June 13, 2025, 14:40 Hrs [IST] Shilpa Biocare, a ful ...

Redcliffe labs study finds higher abnormalities in heart health markers among men than women: Our Bureau, Mumbai Friday, June 13, 2025, 16:40 Hrs [IST] Aiming to raise awareness a ...

EMA accepts for regulatory review GSK’s RSV vaccine, Arexvy to expand use in adults 18 years and older: London, UK Saturday, June 14, 2025, 10:00 Hrs [IST] GSK plc announced tha ...

US FDA approves Nuvation Bio’s taletrectinib for treatment of advanced ROS1-positive non-small cell lung cancer: New York Saturday, June 14, 2025, 14:00 Hrs [IST] Nuvation Bio I ...

Telomir Pharma’s Telomir-1 shows dose-dependent restoration of neurological, liver & kidney functions in preclinical for Wilson’s disease: Miami, Florida Saturday, June 14, 20 ...